Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Z Li

Showing results (181-190 of 270) with videos related to

Pageof 27
Sort By:
The Journal of Infectious Diseases|August 31, 2023
Variant-Specific Viral Kinetics in Acute COVID-19Ruy M Ribeiro, Manish C Choudhary, Rinki Deo, et al.
Open Forum Infectious Diseases|August 25, 2021
Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019James Regan, James P Flynn, Alexandra Rosenthal, et al.
The Journal of Clinical Investigation|June 19, 2018
HIV-1 latent reservoir size and diversity are stable following brief treatment interruptionD Brenda Salantes, Yu Zheng, Felicity Mampe, et al.
The Journal of Infectious Diseases|July 19, 2024
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical TrialKara W Chew, Babafemi O Taiwo, Carlee Moser, et al.
JCI Insight|December 6, 2021
Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infectionsMark J Siedner, Julie Boucau, Rebecca F Gilbert, et al.
The Journal of Infectious Diseases|April 22, 2026
A New Type of Nonsuppressible Viremia Produced by HIV-Infected MacrophageMatthew J Moeser, Olivia D Council, Nathan Long, et al.
Journal of the American Heart Association|November 16, 2022
Mean Coronary Cross-Sectional Area as a Measure of Arterial Remodeling Using Noncontrast CT Imaging in Persons With HIVAyoda T Werede, James G Terry, Sangeeta Nair, et al.
Iscience|March 24, 2025
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodiesRachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Open Forum Infectious Diseases|July 17, 2024
Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From BotswanaWonderful T Choga, Ontlametse T Bareng, Natasha O Moraka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2023
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 TrialNikolaus Jilg, Kara W Chew, Mark J Giganti, et al.
Pageof 27

Showing results (181-190 of 270) with videos related to

Sort By:
Pageof 27
The Journal of Infectious Diseases|August 31, 2023
Variant-Specific Viral Kinetics in Acute COVID-19Ruy M Ribeiro, Manish C Choudhary, Rinki Deo, et al.
Open Forum Infectious Diseases|August 25, 2021
Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019James Regan, James P Flynn, Alexandra Rosenthal, et al.
The Journal of Clinical Investigation|June 19, 2018
HIV-1 latent reservoir size and diversity are stable following brief treatment interruptionD Brenda Salantes, Yu Zheng, Felicity Mampe, et al.
The Journal of Infectious Diseases|July 19, 2024
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical TrialKara W Chew, Babafemi O Taiwo, Carlee Moser, et al.
JCI Insight|December 6, 2021
Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infectionsMark J Siedner, Julie Boucau, Rebecca F Gilbert, et al.
The Journal of Infectious Diseases|April 22, 2026
A New Type of Nonsuppressible Viremia Produced by HIV-Infected MacrophageMatthew J Moeser, Olivia D Council, Nathan Long, et al.
Journal of the American Heart Association|November 16, 2022
Mean Coronary Cross-Sectional Area as a Measure of Arterial Remodeling Using Noncontrast CT Imaging in Persons With HIVAyoda T Werede, James G Terry, Sangeeta Nair, et al.
Iscience|March 24, 2025
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodiesRachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Open Forum Infectious Diseases|July 17, 2024
Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From BotswanaWonderful T Choga, Ontlametse T Bareng, Natasha O Moraka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2023
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 TrialNikolaus Jilg, Kara W Chew, Mark J Giganti, et al.
Pageof 27